Home Conference Coverage

Conference Coverage

Conference Coverage

Pembrolizumab + Axitinib Outperforms Sunitinib in Treatment of Metastatic Renal Cell Carcinoma

Danielle Garcia - November 22, 2020

Study Shows Pembrolizumab to be Safe in Treatment Metastatic Castration-resistant Prostate Cancer

Innovative Risk-assessment Tool Measures Patient’s Local Immune Response to the Cancer

Pro-Inflammatory Response may Identify Cancer Patients at Risk of Adverse Outcomes from COVID-19

Encouraging Clinical Data for Controlled IL-12 for the Treatment of Glioblastoma and DIPG

New Approach to Address the Unmet Medical Need in the Early...

Peter Hofland, Ph.D - November 13, 2020

AACR: The Science of Cancer Health Disparities

Editorial Team - October 2, 2020

ESMO 2020: Derazantinib in Preclinical Models with FGFR Aberrations Supports Gastric...

Peter Hofland, Ph.D - September 22, 2020

ESMO 2020: Tisotumab Vedotin Shows Meaningful Clinical Activity in Cervical Cancer

Peter Hofland, Ph.D - September 21, 2020

ESMO 2020: Sacituzumab Govitecan Shows 27% ORR in Heavily-pretreated Metastatic Urothelial...

Editorial Team - September 20, 2020

Glioblastoma with extreme nuclear enlargement.

ESMO 2020: TERT Promoter Mutations May Not Be Indicative of Sensitivity...

Editorial Team - September 20, 2020

ESMO 2020: First-in-class MK-4830 Antibody Targeting ILT4 Shows Promising Preliminary...

Editorial Team - September 20, 2020

ESMO 2020: Sotorasib Active in Patients with KRAS p.G12C Mutation –...

Editorial Team - September 20, 2020

General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2020: CheckMate 9ER Provides New First-Line Treatment Option for Patients...

Peter Hofland, Ph.D - September 19, 2020

Confirmatory Phase III ASCENT Study Shows Significant Improved Overall Survival in...

Danielle Garcia - September 19, 2020

12 3...32 Page 1 of 32

LATEST NEWS

Dexamethasone Decreases the Efficacy of Immune Checkpoint Inhibitors in Patients With Glioblastoma

Editorial Team - November 27, 2020

Europe Validates Application for Tepotinib for Advanced NSCLC with METex14 Skipping Alterations

Peter Hofland, Ph.D - November 26, 2020

U.S. FDA Approves Naxitamab for the Treatment of Neuroblastoma

Peter Hofland, Ph.D - November 26, 2020

EMA Recommends Approval of Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm

Editorial Team - November 24, 2020

Social Needs Linked to Low Health-Related Quality of Life Among African American Cancer Survivors

Editorial Team - November 23, 2020

Press Releases | Cancer

Mental Health Startup, Taliaz, Inks Partnership Agreement with... December 2, 2020
The agreement will accelerate commercialization of its AI mental health platform, PREDICTIX, in Australia, New Zealand and the USA, pending regulatory approval.(PRWeb December 02, 2020)Read the full story at https://www.prweb.com/releases/mental_health_startup_taliaz_inks_partnership_agreement_with_molecular_diagnostics_leader_genetic_technologies/prweb17580983.htm
Karmanos Cancer Institute to implement OncoLens virtual tumor board... December 1, 2020
Greater collaboration on a secure digital platform across 16 locations will improve continuum of care for patients(PRWeb December 01, 2020)Read the full story at https://www.prweb.com/releases/karmanos_cancer_institute_to_implement_oncolens_virtual_tumor_board_and_cancer_treatment_planning_software_solutions/prweb17578712.htm
BoniMedics partners with scar treatment pioneer, Biodermis® to... November 30, 2020
BoniMedics is bringing Biodermis' proven line of silicone scar treatment products to Sweden, Denmark, Norway and Finland(PRWeb November 30, 2020)Read the full story at https://www.prweb.com/releases/bonimedics_partners_with_scar_treatment_pioneer_biodermis_to_bring_patented_pro_sil_to_northern_europe/prweb17558605.htm